Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06916169
PHASE1
A Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042
Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd
View on ClinicalTrials.gov
Summary
The objective of this study is to evaluate the pharmacokinetic characteristics of AG2304 in healthy subjects.
Official title: An Open-label, Randomized, Fasting, Single, Group 2, Stage 2, Cross-over Study to Evaluate the Safety and Pharmacokinetics of AG2304 Compared to Coadministration of AG23041 and AG23042 in Healthy Adult Volunteers
Key Details
Gender
All
Age Range
19 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
70
Start Date
2025-08
Completion Date
2025-09
Last Updated
2025-04-08
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AG2304
AG2304, Single-dose Oral Administration
DRUG
AG23041 and AG23042
AG23041/AG23042, Single-dose Oral Administration